default author photo

Shashank R Joshi

Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology

SCHOLARLY PAPERS

4

DOWNLOADS

452

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Digital Twin Intervention for Type 2 Diabetes: One-Year Outcomes of a Randomized Trial

Number of pages: 23 Posted: 12 Jul 2023
Shashank R Joshi, Paramesh Shamanna, Mala Dharmalingam, Arun Vadavi, Ashok Keshavamurthy, Lisa Shah, Francine Kaufman, Ambrish Mittal, Sumit Bhagra, Simin Liu and Jeffrey I. Mechanick
Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Bangalore Diabetes Centre, Ramaiah Medical College, Sudha Prevention Centre, Chandana Clinic, Twin Health, Children’s Hospital Los Angeles, Max Healthcare - Endocrinology and Diabetes, Mayo Clinic - Division of Endocrinology, Brown University - Department of Epidemiology and Mount Sinai Health System - The Marie-Josee and Henry R. Kravis Center for Cardiovascular Health
Downloads 214 (356,192)

Abstract:

Loading...

artificial intelligence, asian Indian, body weight, diabetes remission, digital twin, insulin resistance, internet of things, lifestyle medicine, obesity prevention, type 2 diabetes

2.

SARS-CoV-2 Accelerated Clearance Using a Novel Nitric Oxide Nasal Spray (NONS) Treatment

Number of pages: 24 Posted: 22 Mar 2022
Monika Tandon, Rahul Ramesh Kodgule, Keith Moore, Stephen Winchester, Yuan-Po Tu, Chris Miller, Wen Wu, Amol Pendse, Shabbir Rangwala and Shashank R Joshi
Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Sanotize Research and Development Corp., Oxford Health NHS Foundation Trust, Optum Labs, Sanotize Research and Development Corp., Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd and Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology
Downloads 161 (467,092)

Abstract:

Loading...

covid-19, Anti-viral treatment, Nitric Oxide, Nasal Spray

3.

Clinician-Led Digital Innovations in Diabetes Care: Insights from the 2025 JPEF-USV Technology Awards in India

https://doi.org/10.4103/ijdt.ijdt_38_25
Number of pages: 20 Posted: 28 Oct 2025
Banshi Saboo, Shashank R Joshi, Anuj Maheswari, Jothydev Kesavadev, Krishnadev Jothydev, Gopika Krishnan, Anjana Basanth and Thamburaj Anthuvan
Dia Care - Diabetes Hormone Clinic, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Independent, Independent, Government Medical College, Trivandrum, Government Medical College, Trivandrum, Government Medical College, Trivandrum and S.B.Patil Institute of Management
Downloads 50 (1,074,648)

Abstract:

Loading...

Clinician-Led Innovation, Digital Health, Artificial Intelligence, Digital Therapeutics, Patient Empowerment, Diabetes Care

4.

Efficacy and Safety of Fixed-Dose Dapagliflozin-Pioglitazone in Indian Adults with Type 2 Diabetes: Results from the Randomized Phase 3 PRO-1 Trial

Number of pages: 28 Posted: 15 Oct 2025
Awadhesh Kumar Singh, Krishna Seshadri, Ambika G. Unnikrishnan, Jothydev Kesavadev, Sanjay Kalra, Shashank R Joshi, Kaushik Pandit, Rakesh Kumar Sahay, Vijay Panikar, Ambrish Mithal, Smriti Gadia and Thamburaj Anthuvan
GD Hospital & Diabetes Institute - Diabetes & Endocrinology, Apollo Hospital, JSS Academy of Higher Education and Research, Independent, Bharti Hospital, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Institute of Postgraduate Medical Education & Research (IPGMER), Osmania Medical College, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Medanta-The Medicity - Division of Endocrinology and Diabetes, USV Pvt. Ltd and S.B.Patil Institute of Management
Downloads 27 (1,372,601)

Abstract:

Loading...

Type 2 diabetes mellitu, fixed-dose combination, dapagliflozin, pioglitazone, India, Pro 1 Study, MASLD, NAFLD